We are live on ! Find out more
MITO

Stealth BioTherapeutics Corp. ADS
MITO

Delisted

MITO was delisted on the 15th of November, 2022.

Back to rankings

10 hedge funds and large institutions have $947K invested in Stealth BioTherapeutics Corp. ADS in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

100% more funds holding

Funds holding: 5 → 10 (+5)

26% more capital invested

Capital invested by funds: $752K → $947K (+$195K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
10
Holders Change
+5
Holders Change %
+100%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PM
Prosight Management
Texas
+$748K
2
Renaissance Technologies
Renaissance Technologies
New York
+$284K
3
Millennium Management
Millennium Management
New York
+$80.1K
4
PC
PA Capital
Virginia
+$49.9K
5
Two Sigma Investments
Two Sigma Investments
New York
+$27.6K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$14.7K
2
Morgan Stanley
Morgan Stanley
New York
-$11.1K

MITO Hedge Fund Activity: Q1 2020 in Review

10 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Stealth BioTherapeutics Corp. ADS (MITO) for Q1 2020, worth a combined $947K — up 26% from $752K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new MITO positions and 1 closed out — a net gain of 5 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Prosight Management, opening a new position worth an estimated $748K. The largest seller was UBS Group, cutting an estimated $14.7K.

  • 10 institutional investors held Stealth BioTherapeutics Corp. ADS (MITO) as of Q1 2020, up from 5 in Q4 2019.
  • Funds reported $947K of Stealth BioTherapeutics Corp. ADS stock for Q1 2020, up 26% quarter-over-quarter.
  • 6 funds opened new Stealth BioTherapeutics Corp. ADS positions in Q1 2020 and 1 closed out, a net change of +5 holders.
  • The largest Stealth BioTherapeutics Corp. ADS buyer in Q1 2020 was Prosight Management, an estimated $748K added.
  • The largest Stealth BioTherapeutics Corp. ADS seller in Q1 2020 was UBS Group, an estimated $14.7K sold.

Based on aggregated 13F filings for Q1 2020.